Could a snore device also fight gum disease?
NCT ID NCT06797089
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a special oral appliance called myTAP, combined with a mouth shield and deep dental cleaning, can reduce gum disease in people who snore and breathe through their mouth. 43 adults with mild to moderate gum disease completed the 12-week trial. The device aims to improve breathing during sleep and reduce mouth breathing, which may help gum health.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- myTAP oral appliance with mouth shield
- What this could lead to
- If it works, this could point toward a non-drug way to manage gum disease in people who mouth-breathe and snore.
- What could go wrong
- This is a small, early-stage study with only 43 people. Results may not apply to everyone, and the device may not improve gum health for all users.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
43 people
The number who actually took part.
- Started
-
Apr 2024
- Finished
-
Jan 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Mouth breathing and snoring confirmed by home sleep test (NOX T3; ≥4 snores/hour) and complaints of excessive daytime sleepiness 2. Seeking treatment for periodontitis (stage 1 or 2 as confirmed by full periodontal examination at Visit 1 or 2) 3. Adults 18-85 years old 4. Stable medical condition (e.g., diabetes or hypertension properly managed) 5. At least 8 natural maxillary teeth to support the oral appliance 6. Mallampati score from I to III; Palatine tonsils - grade 0, 1, or 2 7. Central and mixed apnea index \< 5 events/hour 8. Able to speak, read, and comprehend English fluently 9. At least 12 years of education 10. Ability to apply and remove home sleep recorder Willingness to... 11. Share PHI, medication list, current and past medical and dental information with research team members as needed 12. Follow all oral hygiene instructions and attend all appointments (periodontal and otherwise) as stipulated by the protocol 13. Allow the collection of plaque and waste materials from periodontal procedures and allow them to be evaluated for bacterial DNA (not human DNA) 14. Provide saliva samples (spit into tube) 15. Wear the oral appliance (OA) nightly as instructed for 12 weeks and with the mouth-shield (OA+) for the last 8 weeks 16. Complete brief surveys on sleep and related subjective experiences 17. Communicate with the clinical research coordinator regarding OA titration 18. Continue current medication and supplement use 19. Wait till the end of 12-week experimental period to complete periodontal therapy; this will include scaling, root planing of untreated side of dentition as well as redoing the treated side Exclusion Criteria 1. Gingival probing depths \> 5mm 2. Tooth mobility score greater than 2 3. Severe xerostomia 4. Severe medical illness such as symptomatic chronic obstructive pulmonary disease, renal failure, symptomatic coronary or cerebral vascular disease, cardiac dysrhythmia (i.e., atrial fibrillation); pacemaker; cardiopulmonary dysfunction (i.e., chronic heart failure), 5. Severe psychiatric and neurological disorders such as current substance abuse (including alcohol, nicotine); major depression and psychotic disorder; seizure disorder 6. Morbid obesity (Body Mass Index: BMI ≥35) 7. Active temporomandibular joint disorder (TMD) or jaw muscle pain; persistent history of TMD 8. Diagnosis of severe periodontitis 9. Morphological airway abnormalities (malformations of throat; e.g., a very small airway due to a condition such as severe micrognathia or Pierre Robin Syndrome) 10. Restrictions in jaw opening (difficult opening mouth widely) \< 30 mm 11. Pre-existing difficulty swallowing; throat or neck related health issues; 12. Previous major surgery to throat and surrounding area such as UPPP (uvulopalatopharyngoplasty) 13. Intellectual disability that would prevent giving informed consent 14. Serious hormonal disease (endocrine dysfunction such as Addison's disease, Cushing's disease, hyperthyroidism); Diabetes and osteoporosis are OK) 15. Pregnant, breast feeding or intent to become pregnant during the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Daytime sleepiness are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Texas A&M University College of Dentistry
Dallas, Texas, 75246, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday supplements boost gum disease therapy?
- Can pulling a loose tooth and putting it back save it?
- Gum fluid proteins eyed as link between smoking and periodontitis
- Gum fluid holds clues to Behçet's disease puzzle
- Magnifying the fight against gum disease: loupe vs microscope
- Can teaching people with diabetes to care for their gums also help their blood sugar?